BiotechTube
Home/GlycoMira/William P. Tew, Ph.D.
WP

William P. Tew, Ph.D.

CEO, Chairman of the Board, Director

GlycoMira

Therapeutic Areas

OncologySupportive Care

GlycoMira Pipeline

DrugIndicationPhase
GM-1111Solid Tumors (e.g., Colorectal, Lung, Renal, Breast, Endometrial)Phase 1